ANTH

Anthera Pharmaceuticals, Inc. News Headlines

$1.82
*  
0.025
1.36%
Get ANTH Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading ANTH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns
11/7/2014 9:16:00 AM - Seeking Alpha


Qiagen's Molecular Diagnostics, Global Market Show Strength - Analyst Blog
9/26/2014 1:50:00 PM - Zacks.com


Genomic Health Upbeat on Strong International Performance - Analyst Blog
9/25/2014 2:00:00 PM - Zacks.com


Zacks Rank #1 Additions for Thursday - Tale of the Tape
9/25/2014 8:30:00 AM - Zacks.com


Anthera (ANTH) Enters Oversold Territory - Tale of the Tape
8/11/2014 9:41:13 AM - Zacks.com


Anthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
8/4/2014 8:31:28 AM - Zacks.com


Anthera Acquires Sollpura from Eli Lilly - Analyst Blog
7/18/2014 4:20:00 PM - Zacks.com


Sector Update: Health Care Stocks Swept Up in Biotech Sell-Off as Fed Sees Values 'Stretched'
7/15/2014 12:25:04 PM - MT Newswires


Sector Update: Health Care
7/15/2014 12:08:41 PM - MT Newswires


Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape
7/15/2014 8:04:00 AM - Zacks.com


Fire Up The Immuno-Oncology Powerhouses: John McCamant
6/19/2014 5:39:00 PM - Seeking Alpha


Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape
5/16/2014 7:51:00 AM - Zacks.com


Anthera Pharmaceuticals: Recent Developments, Both Good And Bad
10/31/2013 1:20:00 PM - Seeking Alpha


A Promising Future For Anthera's Blisibimod
9/27/2013 5:58:00 PM - Seeking Alpha


BioLineRx Files for BL-7010 Study Initiation - Analyst Blog
9/25/2013 4:25:01 PM - Zacks.com


Biogen Upped to Outperform - Analyst Blog
9/19/2013 10:30:01 AM - Zacks.com


Data Published on Alnylam's ATTR Candidates - Analyst Blog
8/29/2013 3:34:43 PM - Zacks.com


Voluntary Recall at Alexion - Analyst Blog
8/21/2013 10:25:24 AM - Zacks.com


MannKind to Raise $40M from Deerfield - Analyst Blog
8/19/2013 9:25:30 AM - Zacks.com


ANTH's Blisibimod Enters Phase III - Analyst Blog
4/1/2013 6:11:38 PM - Zacks.com


Anthera Shifts Its Strategy For Blisibimod
1/23/2013 11:56:00 AM - Seeking Alpha


Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
11/29/2012 8:11:00 AM - Seeking Alpha


Anthera Recovering After Long Fall
11/27/2012 10:39:00 AM - Seeking Alpha


Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster
11/14/2012 11:28:00 AM - Seeking Alpha


GlaxoSmithKline: Buy For 4.5% Yield
10/8/2012 10:03:00 AM - Seeking Alpha